Cite
Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by circulating tumour DNA in peripheral T‐cell lymphoma.
MLA
Wei, Chong, et al. “Mutation Profiling, Tumour Burden Assessment, Outcome Prediction and Disease Monitoring by Circulating Tumour DNA in Peripheral T‐cell Lymphoma.” British Journal of Haematology, vol. 202, no. 1, July 2023, pp. 86–95. EBSCOhost, https://doi.org/10.1111/bjh.18824.
APA
Wei, C., Wang, W., Zhang, Y., Zhao, D., Zhang, W., & Zhou, D. (2023). Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by circulating tumour DNA in peripheral T‐cell lymphoma. British Journal of Haematology, 202(1), 86–95. https://doi.org/10.1111/bjh.18824
Chicago
Wei, Chong, Wei Wang, Yan Zhang, Danqing Zhao, Wei Zhang, and Daobin Zhou. 2023. “Mutation Profiling, Tumour Burden Assessment, Outcome Prediction and Disease Monitoring by Circulating Tumour DNA in Peripheral T‐cell Lymphoma.” British Journal of Haematology 202 (1): 86–95. doi:10.1111/bjh.18824.